. Kết quả PCR chẩn đoán lậu cầu với cặp mồi HO1 – HO3 Giếng 1 đến 6: các bệnh phẩm d− ơng tính với PCR, giếng
Tμi liệu tham khảo
Tài liệu tiếng Việt
1. Vũ Tuấn Anh (2003), Tình hình, đặc điểm lâm sàng và giá trị chẩn đoán của PCR trong nhiễm Chlamydia trachomatis đ−ờng sinh dục, Luận văn Thạc sỹ Y học, Học viện Quân Y.
2. Nguyễn Thị Thanh Huyền (2002), Nghiên cứu tình hình nguyên nhân và đặc điểm lâm sàng hội chứng tiết dịch đ−ờng sinh dục d−ới ở phụ nữ đến khám lại Viện Da liễu, Luận văn Thạc sỹ Y học, Tr−ờng Đại học Y Hà Nội, Hà Nội.
3. Diệp Xuân Thanh (1999), Tình hình nhiễm trùng sinh dục do lậu cầu và chlamydia trachomatis tại Viện Da Liễu 2 năm 1997-1998, Luận văn Thạc sỹ Y học, Tr−ờng Đại học Y Hà Nội, Hà Nội.
4. Nguyễn Thị Ngọc Yến, Trần Hậu Khang (2002), Điều trị nhiễm trùng đ−ờng tình dục do Chlamydia trachomatis bằng Zithromax, Y học thực hành, 471(3), 27-29.
Tài liệu tiếng Anh
5. Baud D. et al (2008), Low prevalence of Chlamydia trachomatis infection in asymptomatic young Swiss men, BMC Infectious Diseases, 8, 45-52.
6. Bergen J.V. (2006), Population prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in the Netherlands. should asymptomatic persons be tested during Population-based chlamydia Screening also for gonorrhoea or only if chlamydial infection is found?, BMC Infectious Diseases, 6:42.
7. Black C.M. (1997), Current Methods of Laboratory Diagnosis of Chlamydia trachomatis Infections, Clin. Microbiol. Reviews., 10(1), 160-184.
8. Boyadzhyan B. et al (2004), Comparison of the APTIMA CT and GC Assays with the APTIMA Combo 2 Assay, the Abbott LCx Assay, and Direct Fluorescent-Antibody and Culture Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae, J. Clin. Microbiol., 42(7), 3089-3093.
9. Burstein G.R. et al (2001), Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females, Sex. Transm. Inf., 77, 26–32.
10.Carroll. K.C. et al (1998), Evaluation of the Abbott LCx Ligase Chain Reaction Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine and Genital Swab from Sexually Transmitted Disease Clinic Population, J. Clin. Microbiol., 36(6), 1630-1633.
11.Centers for Disease Control and Prevention (2007), Sexually Transmitted Disease Surveillance, 2006. Atlanta, USA.
12.Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993, MMWR 42(No. RR-12).
13.Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2006, MMWR 55(No. RR-11).
14.Chen K.T. et al (2007), Chlamydial infection among patients attending STD and genitourinary clinics in Taiwan, BMC Public Health, 7, 120. 15.Chtistian P. et al (2005), Prevalence and risk factors of chlamydia and
gonorrhea among rural Nepali women, Sex. Transm. Infect., 81, 254– 258.
16.Cohan D. (2006), Sex worker health: San Francisco style, Sex. Transm. Infect., 82(5), 418-422.
17.Cook R.L. et al (2005), Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae, Ann. Intern. Med., 142, 914-25.
18.Dayan L. (2006), Pelvic inflammatory disease, Australian Family Physician, 35(11), 858-862.
19.Dhawan B. et al (2006), Evaluation of the diagnostic efficacy of PCR for Ureaplasma urealyticum infection in Indian adults with symptoms of genital discharge, Jpn. J. Infect. Dis., 59(1), 57-58.
20.Dicker L.W. et al (2003), Gonorrhea Prevalence and Coinfection With Chlamydia in Women in the United States, 2000, Sex. Transm. Dis., 30(5), 472-476.
21.Dowe G. et al (1999), High prevalence of genital Chlamydia trachomatis infection in women presenting in different clinical settings in Jamaica: implications for control strategies, Sex. Transm. Inf., 75, 412-416.
22.Dreses-Werringloer U. et al (2001), Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro, Antimicrob. Agents Chemother., 45(11), 3001-3008.
23.Duncan M.E. et al (1992), Seroepidemiological and socioeconomic studies of genital chlamydial infection in Ethiopian women, Genitourin. Med., 68, 221-227.
24.Ehret J.M et al (1993), Chlamydiae, in Antimicrobial agents and intracellular pathogens, edited by Didier, CRC Press, Inc., USA.
25.Erlich H.A. (1989), PCR technology – Principles and applications for DNA amplification, Stockton Press, USA.
26.Garrow S.C. et al (2002), The diagnosis of chlamydia, gonorrhoea, and trichomonas infections by self obtained low vaginal swabs, in remote northern Australian clinical practice, Sex. Transm. Infect., 78, 278-81. 27.George J.A. et al (2003), Evaluation of diagnostic efficacy of PCR
methods for Chlamydia trachomatis infection in genital and urine specimens of symtomatic men and women in India, Jpn. J. Infect. Dis., 56, 88-92.
28.Hashemi F.B. et al (2007), Frequency of Chlamydia trachomatis inWomen with Cervicitis in Tehran, Iran, Infectious Diseases in Obstetrics and Gynecology, Volume 2007, 1-4.
29.Herrmann B. et al (1996), Genital chlamydial infection among women in Nicaragua: validity of direct fluorescent antibody testing, prevalence, risk factors and clinical manifestations, Genitourin. Med., 72, 20-26. 30.Hoosen A.A. et al (1993), Microbiology of acute epididymitis in a
developing community, Genitourin. Med., 69:361-363
31.Iser P. et al (2005), Symptoms of non-gonococcal urethritis in heterosexual men: a case control study, Sex. Transm. Infect. 81, 163– 165.
32.Ishi K. et al (2000), Prevalence of Human Papillomavirus, Chlamydia trachomatis, and Neisseria gonorrhoeae in Commercial Sex Workers in Japan, Infectious Diseases in Obstetrics and Gynecology, 8, 235-239. 33.Jang D. et al (2003), Correlation between culture testing of swabs and
ligase chain reaction of first void urine from patients recently treated for Chlamydia trachomatis, Sex. Transm. Infect., 79, 237–239.
34.Jaton K. et al (2006), A novel real-time PCR to detect Chlamydia trachomatis in first-void urine or genital swabs, J. Med. Microbiol., 55, 1667-1674.
35.Jones R. et al (2007), Screening for Chlamydia trachomatis, BMJ, 334, 703-704.
36.Kouri V. et al (2002), Prevalence of Chlamydia trachomatis in Human Immunodeficiency Virus-infected Women in Cuba, Mem. Inst. Oswaldo Cruz, Rio de Janeiro, 97(8), 1073-1077.
37.Kucinskiene V. et al (2006), Prevalence and risk factors of genital Chlamydia trachomatis infection, Medicina (Kaunas, 42(10), 885-894. 38.Levallois B. et al (1987), ChIamydial infection among females
attending an abortion clinic: prevalence and risk factors, CMAJ, 137, 33-37.
39.Lindan C. et al (2005), Utility of Pooled Urine Specimens for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Men Attending Public Sexually Transmitted Infection Clinics in Mumbai, India, by PCR, J. Clin. Microbiol., 43(4), 1674-1677.
40.Louie M. et al (2000), The role of DNA amplification technology in the diagnosis of infectious diseases, CMAJ, 163(3), 301-9.
41.Low N. et al (2006), Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women’s Cohort Study, Sex. Transm. Inf., 82, 212-218. 42.Lyss S.B. et al (2003), Chlamydia trachomatis among Patients Infected
with and Treated for Neisseria gonorrhoeae in Sexually Transmitted Disease Clinics in the United States, Ann. Intern. Med., 139, 178-185. 43.Mahilum-Tapay L. et al (2007), New point of care Chlamydia Rapid
Test—bridging the gap between diagnosis and treatment: performance evaluation study, BMJ, 335, 1190-1194.
44.Mahony J. et al (1998), Urine Specimens from Pregnant and Nonpregnant Women Inhibitory to Amplification of Chlamydia trachomatis Nucleic Acid by PCR, Ligase Chain Reaction, and
Transcription-Mediated Amplification: Identification of Urinary Substances Associated with Inhibition and Removal of Inhibitory Activity, J. Clin. Microbiol., 36(11), 3122-6.
45.Mahony J.B. et al (1992), Confirmatory Polymerase Chain Reaction Testing for Chlamydia trachomatis in First-Void Urine from symptomatic and Symptomatic Men, J. Clin. Microbiol., 30(9), 2241- 2245.
46.Mahony J.B. et al (1993), Comparison of Plasmid- and Chromosome- Based Polymerase Chain Reaction Assays for Detecting Chlamydia trachomatis Nucleic Acids, J. Clin. Microbiol., 31(7), 1753-1758.
47.Malik A. et al (2006), Chlamydia trachomatis infection & female infertility, Indian. J. Med. Res., 123, 770-775.
48.Mania J. et al (2001), Chlamydia trachomatis infection among asymptomatic males in an infertility clinic, Indian. J. Dermatol. Venereol. Leprol., 67(5), 242-245.
49.Marbet U.A. et al (1986), Diffuse peritonitis and chronic ascites due to infection with Chlamydia trachomatis in patients without liver disease: new presentation of the Fitz-Hugh-Curtis syndrome, Bristish Medical Journal (293), 5-6.
50.Marshall R. et al (2007), Characteristics of the m2000 Automated Sample Preparation and Characteristics of the m2000 Automated Sample Preparation and Chlamydia trachomatis and Neisseria gonorrhoeae, J. Clin. Microbiol., 45(3), 747-751.
51.Meyers D.S. et al (2007), Screening for Chlamydial Infection: An Evidence Update for the U.S. Preventive Services Task Force, Ann. Intern. Med., 147(2), 135-142.
52.Miller W.C. (2004), Prevalence of Chlamydial and Gonococcal Infections Among Young Adults in the United States, JAMA, 291, 2229-2236.
53.Moruse D.J. et al (1996), Predictors of Chlamydia trachomatis Infection among Female Adolescents: A Longitudinal Analysis, Am. J. Epidemiol., 144(10), 997-1003.
54.Navarro C. et al (2002), Risk factors for genital chlamydial infection, Can. J. Infect. Dis., 13(3), 195-207.
55.Nsuami M. et al (2004), Chlamydia and Gonorrhea Co-occurrence in a High School Population, Sex. Transm. Dis., 31(7), 424–427.
56.Okoror L.E. et al (2007), Prevalence of chlamydia in patients attending gynecological clinics in south eastern Nigeria, African Health Sciences, 7(1), 18-24.
57.Paavonen J. et al (1999), Chlamydia trachomatis: impact on human reproduction, Human Reproduction Update, 5(5), 433-447.
58.Paludan K. et al (1993), “Polymerase chain reaction and dermatology”, Acta. Derm. Venereol., 73, 1-6.
59.Passey M. et al (1998), Community based study of sexually transmitted diseases in rural women in the highlands of Papua New Guinea: prevalence and risk factors, Sex. Transm. Inf., 74, 120–127.
60.Powell J. et al (2004), Chlamydia trachomatis prevalence in men in the mid-west of Ireland, Sex. Transm. Infect., 80, 349–353.
61.Reiss J. (1991), “The polymerase chain reaction and its potential role in clinical diagnostics and research”, J. Intern. Med., 230, 391-395.
62.Robert T.E. et al (2007), Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project, BMJ, 335, 291-297.
63.Romoren M. et al (2007), Chlamydia and gonorrhoea in pregnant Batswana women: time to discard the syndromic approach?, BMC Infectious Diseases, 7(27).
64.Saison F. (2007), Prevalence of Chlamydia trachomatis Infection among Low- and High-Risk Filipino Women and Performance of Chlamydia Rapid Tests in Resource-Limited Settings, J. Clin. Microbiol., 45(12), 4011-4017.
65.Schachter J. et al (1998), Chlamydial diseases, in Microbiology and microbial infections, Arnold and Oxford University Press, Inc., USA. 66.Simms I. et al (2006), Risk factors associated with pelvic inflammatory,
Sex. Transm. Inf. 82, 452-457.
67.Skjeldestad F.E. et al (1997), Sentinel surveillance of Chlamydia trachomatis infection in women terminating pregnancy, Genitourin. Med., 73, 29-32.
68.Tait I.A. et al (2002), Chlamydia trachomatis in non-gonococcal urethritis patients and their heterosexual partners: routine testing by polymerase chain reaction, Sex. Transm. Infect., 78, 286–288.
69.Tebb K.P. et al (2003), Screening Sexually Active Adolescents for Chlamydia trachomatis : What About the Boys?, Am. J. Public Health, 95, 1806–1810.
70.Vuylsteke B. et al (1999), Chlamydia trachomatis prevalence and sexual behaviour among female adolescents in Belgium, Sex. Transm. Inf., 75, 152–155.
71.Watson E.J. et al (2002), The accuracy and efficacy of screening tests for Chlamydia trachomatis a systematic review, J. Med. Microbiol., 51, 1021-31.
72.WHO (2003), Guidelines for the management of sexually transmitted infections, Geneva, Switzerland.
73.WHO (2007), Global strategy for prevention and control of sexually transmitted infections: 2006-2015, Geneva, Switzerland.
74.Witkin S.S. et al (1997), Detection of endocervical anti-Chlamydia trachomatis immunoglobulin A in pregnant women by a rapid, 6-minute enzyme-linked immunosorbent assay: comparison with PCR and chlamydial antigen detection methods, J. Clin. Microbiol., 35(7), 1781- 1783.
75.Zimmerman H.L. et al (1990), Epidemiologic Differences between Chiamydia and Gonorrhea, AJPH, 80(11), 1338-1342.
Phụ lục